Helius Medical Technologies Stock Surges 250% on $500M Solana Treasury Raise

Helius Medical Technologies Stock Surges 250% on $500M Solana Treasury Raise

Helius Medical Technologies stunned markets Monday after announcing an oversubscribed $500 million fundraising round to launch a Solana-focused digital asset treasury strategy. The move sent its stock soaring 250% in pre-market trading, highlighting growing institutional interest in Solana as a reserve asset.

A Major Crypto-Fueled Treasury Bet

The private investment in public equity (PIPE) offering was led by Pantera Capital and Summer Capital, with participation from a roster of well-known crypto investors including Big Brain Holdings, Avenir, SinoHope, FalconX, Arrington Capital, Animoca Brands, Aspen Digital, Borderless, Laser Digital, HashKey Capital, and Republic Digital.

Helius said the offering could ultimately reach $1.25 billion when including an additional $750 million in stapled warrants. Closing is expected around September 18, pending standard conditions.

Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company
Preeminent SOL-backed treasury vehicle - with potential to deliver over $1.25 billion - unlocks capital markets to accelerate Solana’s growth The offering was…

Proceeds will be used to acquire SOL, Solana’s native token, which will serve as Helius’s primary reserve asset. The company pointed to Solana’s scalability, widespread adoption, and roughly 7% native staking yield as key drivers for the decision.

Strategic Vision Backed by Industry Leaders

Pantera founder and managing partner Dan Morehead called Solana “a category-defining blockchain” and said Helius’s strategy could expand institutional and retail access to the network worldwide.

The company will be led by a team with deep roots in finance and crypto, including Joseph Chee (founder of Summer Capital), Cosmo Jiang (general partner at Pantera), and Morehead, who will serve as a strategic advisor. Helius plans to scale its SOL position over the next 12–24 months while exploring staking and decentralized finance (DeFi) opportunities under a conservative risk framework.

Shares will continue trading on Nasdaq under the ticker HSDT, with the new strategy taking effect immediately. The firm also pledged transparency around its holdings and ongoing engagement with the Solana community.

Market Reaction and Growing Solana Treasuries

Following the announcement, HSDT spiked from Friday’s close of $7.56 to $25.85 on Monday morning, according to TradingView.

Helius Medical Technologies, Inc.

Helius joins a growing list of companies accumulating Solana. Earlier this year, Galaxy Digital, Jump Crypto, and Multicoin Capital committed $1.65 billion to Forward Industries, a Solana treasury company. Other notable SOL holders include DeFi Development Corp., Sol Strategies, and Upexi.

Clearing Up the Name Confusion

The announcement also sparked confusion within the crypto community due to Helius Medical Technologies sharing a name with Helius Labs, a Solana infrastructure firm. Helius Labs quickly clarified it has no involvement in the deal.

“We are not associated with the Helius which raised money in the public markets today,” the company posted on X. CEO Mert Mumtaz added: “I’ve already received 50+ messages. IT IS NOT ME. I’m not involved with this at all—the name is yet another coincidence.”

Read more